Pharmacy Daily

Bad debt hits result

-

SIGMA'S $100.2 million “underlying profit” (see main story) was impacted by the previously announced one-off $11.4 million insurance recovery and an $8.3 million doubtful debt provision relating to a single pharmacy group.

CEO Mark Hooper stressed that “while disappoint­ing, they are both one-off impacts reflecting historical issues and are not reflective of systemic operationa­l or structural issues”.

Newspapers in English

Newspapers from Australia